182 related articles for article (PubMed ID: 9669189)
1. Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.
Fischer P; Tauscher J; Küfferle B; Kasper S
Int Clin Psychopharmacol; 1998 Mar; 13(2):83-6. PubMed ID: 9669189
[TBL] [Abstract][Full Text] [Related]
2. Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression.
Bouwer C; Stein DJ
S Afr Med J; 1997 Apr; 87(4 Suppl):534-7, 540. PubMed ID: 9180827
[TBL] [Abstract][Full Text] [Related]
3. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.
Landén M; Björling G; Agren H; Fahlén T
J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700
[TBL] [Abstract][Full Text] [Related]
5. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.
Joffe RT; Schuller DR
J Clin Psychiatry; 1993 Jul; 54(7):269-71. PubMed ID: 8335654
[TBL] [Abstract][Full Text] [Related]
6. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Blier P; Bergeron R; de Montigny C
Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
[TBL] [Abstract][Full Text] [Related]
7. Buspirone augmentation of antidepressant therapy.
Dimitriou EC; Dimitriou CE
J Clin Psychopharmacol; 1998 Dec; 18(6):465-9. PubMed ID: 9864079
[TBL] [Abstract][Full Text] [Related]
8. Possible augmentation of antidepressant response by buspirone.
Jacobsen FM
J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic antidepressant augmentation.
Sussman N
J Clin Psychiatry; 1998; 59 Suppl 5():42-8; discussion 49-50. PubMed ID: 9635547
[TBL] [Abstract][Full Text] [Related]
10. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
[TBL] [Abstract][Full Text] [Related]
11. Augmentation strategies to increase antidepressant efficacy.
Shelton RC
J Clin Psychiatry; 2007; 68 Suppl 10():18-22. PubMed ID: 17900205
[TBL] [Abstract][Full Text] [Related]
12. Medication augmentation after the failure of SSRIs for depression.
Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
[TBL] [Abstract][Full Text] [Related]
13. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases.
Thomsen PH; Mikkelsen HU
Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463
[No Abstract] [Full Text] [Related]
14. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
Abbas S; Chandra PS; Srivastava M
J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
[No Abstract] [Full Text] [Related]
15. Buspirone as an antidote to SSRI-induced bruxism in 4 cases.
Bostwick JM; Jaffee MS
J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633
[TBL] [Abstract][Full Text] [Related]
16. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
Spigset O; Adielsson G
Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
[No Abstract] [Full Text] [Related]
17. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.
Robinson DS; Rickels K; Feighner J; Fabre LF; Gammans RE; Shrotriya RC; Alms DR; Andary JJ; Messina ME
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):67S-76S. PubMed ID: 2198303
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.
Sabuncuoglu O; Ekinci O; Berkem M
Spec Care Dentist; 2009; 29(5):215-7. PubMed ID: 19740153
[TBL] [Abstract][Full Text] [Related]
19. 'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527.
Lawlor B
Int J Geriatr Psychiatry; 1998 Jul; 13(7):496. PubMed ID: 9695043
[No Abstract] [Full Text] [Related]
20. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.
Papakostas GI; Chuzi SE; Sousa JL; Fava M
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):175-80. PubMed ID: 19641981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
